Clinical trial
Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034
NCT00358384 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00358384 |
|---|---|
| Title | Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034 |
| Official title | A Study to Investigate the Irritation Potential on Healthy Intact Skin and Effect on Psoriatic Skin of Topical Applications of GW786034 |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | Pazopanib, Pazopanib vehicle, Betamethasone valerate, Calcipotriol |
| Enrollment | 10 |
| Start date | Sep 26, 2005 |
| Primary completion | Feb 24, 2006 |
| Completion | Feb 24, 2006 |
| First posted | Jul 31, 2006 |
| Last update posted | Nov 13, 2017 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: